ASIAP Team (from website)
AISAP and Nevia Bio, formerly Gina Life, are two new Israeli startups using Artificial Intelligence (AI) for different purposes: One for women’s health and the other for medical purposes.
AI has been in the news a lot lately for how it is able to produce all manner of writing, among other things, leaving professional writers scared about losing their jobs. But it is also used in the fields of science and medicine to help treat all manner of diseases.
Co-founded by CEO Inbal Zafir-Lavie, PhD, Chief Scientist Shlomit Yehudai-Reshef, PhD and Prof. Roni Michaely, Nevia Bio, is a femtech company developing a platform for early detection in women’s health. The firm uses proprietary biomarker panels in secretions empowered by AI to enable early detection of women’s health diseases.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
With the use of a unique proprietary biomarkers panel supported by AI and data science, a personalized test will be generated for every woman, enabling early detection of women related diseases.
Located in Tel Aviv and founded by Chief Medical Officer Prof. Robert Klempfner and CEO Adiel Am-Shalom, AISAP Ltd is the brainchild of a multidisciplinary team of AI & Deep learning top-notch experts and leading physicians with deep clinical and research expertise. The AISAP platform is a high-performance AI solution for real-time diagnosis, interpretation, storing, and reporting of ultrasound studies at the point of care.
Inbal Zafir-Lavie has vast experience in leading IND enabling studies, developing CLIA compliant lab tests, performing due diligence for new drugs and technologies, supporting FDA IND and 510(k) submissions. She is an expert in the fields of gene therapy, molecular immunology, and antibody engineering and graduated with a PhD (direct course) cum laude, from Technion- Israel institute of technology.
AISAP boasts a user-friendly SAAS platform with AI-powered ultrasound diagnosis. From scan to report within minutes as well as real-time scanning assistance for best image acquisition. Thus, says the firm, can improve performance by data driven analytics and insights to the operator and it also “seamlessly integrates” with any point of care ultrasound device (POCUS) and with electronic health systems protocols and API’s.
Ultrasound is a medical imaging technique that uses high-frequency sound waves to create images of the inside of the body. It is a safe and painless procedure that can be used to diagnose a wide range of medical conditions.
An ultrasound machine uses a transducer to emit sound waves into the body. The sound waves are reflected back to the transducer by different tissues in the body, depending on their density. The transducer then converts these reflected sound waves into electrical signals that are displayed on a monitor as an image.
Ultrasound images can be used to see the size, shape, and structure of organs and tissues in the body. They can also be used to see blood flow and to measure the thickness of tissues.
AISAP is supported by Sheba Medical Venter’s ARC digital innovation infrastructure, which accentuates a unique strategy, one that Accelerates innovation and Redesigns healthcare by Collaborating with partners. ARC says that its mission is to transform healthcare delivery and improve patient care through innovation.
